Cargando…
Silencing RORγt in Human CD4(+) T cells with CD30 aptamer-RORγt shRNA Chimera
Targeting specific T cell subtypes and intervening in their function are emerging a critical strategy for treatment of autoimmune diseases. Here we report that an RNA CD30 aptamer was utilized to deliver short hairpin RNA (shRNA) to CD30(+) T cells to target retinoic acid receptor-related orphan rec...
Autores principales: | Shi, Xiaofei, Song, Pingfang, Tao, Shao, Zhang, Xiaowei, Chu, Cong-Qiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637186/ https://www.ncbi.nlm.nih.gov/pubmed/31316164 http://dx.doi.org/10.1038/s41598-019-46855-9 |
Ejemplares similares
-
Digoxin, an Overlooked Agonist of RORγ/RORγT
por: Karaś, Kaja, et al.
Publicado: (2019) -
The Dichotomous Nature of AZ5104 (an EGFR Inhibitor) Towards RORγ and RORγT
por: Karaś, Kaja, et al.
Publicado: (2019) -
The Th17 immune response is controlled by the Rel–RORγ–RORγT transcriptional axis
por: Ruan, Qingguo, et al.
Publicado: (2011) -
The application of machine learning methods to the prediction of novel ligands for RORγ/RORγT receptors
por: Bachorz, Rafał A., et al.
Publicado: (2023) -
RORα and RORγ expression inversely correlates with human melanoma progression
por: Brożyna, Anna A., et al.
Publicado: (2016)